SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Mergers and acquisitions

The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.

Targeted drug delivery driving partnerships, says expert

06-Feb-2014 - An increased trend in dealmaking for targeted drug delivery last year will continue to drive partnerships in 2014, according to a pharmaceutical partnering expert.

Lupin buys Dutch delivery tech firm for injectables entry

03-Feb-2014 - Lupin Ltd has bought Dutch delivery technology company Nanomi BV in a deal that moves the Indian generics firm into the complex injectables space.

Hospira intent on growing Indian ops as EU market beckons

23-Jan-2014 - Increased in-house API production and manufacturing in India will lower the costs of Hospira’s injectables, the firm says, as it looks past current remediation efforts.

Complex generics will boost speciality biz, Teva says

16-Jan-2014 - Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.

Alnylam buys Merck's siRNA tech biz as Sanofi inks $700m alliance

13-Jan-2014 - Alnylam has both acquired Merck & Co. subsidiary Sirna therapeutics and extended an alliance with Genzyme in order to advance its small interfering RNA (siRNA) delivery programme.

Philips licenses Aerogen's delivery tech

07-Jan-2014 - Aerogen has licensed its respiratory drug delivery technology to Dutch electronics giant Philips in a deal announced today.

Heparin consolidation: Hepalink to buy SPL for $337m

06-Jan-2014 - Chinese API firm Shenzhen Hepalink has announced plans to buy Scientific Protein Laboratories (SPL) from private equity investor American Capital for $337.5m.

Encap selected to formulate Lipocine's HPAPI oral testosterone

18-Dec-2013 - Encap has collaborated with Lipocine to manufacture its oral testosterone product and says it expects continued growth in demand for HPAPI formulation services.

UPDATE

Over-capacity and patent loss sees Pfizer & Merck shutter Puerto Rico plants

25-Nov-2013 - Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.

Aptar launches biologics focused auto-injector

21-Nov-2013 - Aptar Pharma has launched a new auto-injector technology as part of a strategic effort to build its presence in the biopharmaceutical sector.

Granules India to buy Auctus and says Singapore closure is a 'non-event'

04-Nov-2013 - Granules India has outlined plans to buy drug intermediate and API maker Auctus Pharma, set up an actives R&D site and announced its intention to wind up its ‘shell’ operation...

Capsugel and Bend: 'Marriage made in heaven' as first tech transferred

31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.

DISPATCHES FROM CPhI

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

MedImmune looks to 'next generation biologics' with $200m ADC investment

15-Oct-2013 - AstraZeneca has become the latest company to invest in antibody-drug conjugate (ADC) technology with the acquisition of Spirogen for $200m (€148m).

Merck & Co.'s New Jersey rejig has some manufacturing implications

09-Oct-2013 - Merck says it is shutting two New Jersey facilities as it moves its headquarters to the Kenilworth site where manufacturing ended last week.

Capsugel to Buy Bend Research to Expand Bioavailability Offering

05-Sep-2013 - Capsugel will buy Bend Research to expand its dosage form solutions (DFS) business in a deal announced earlier today.

GSK in Talks with Several Firms for Romanian Oral Dose Plant

05-Sep-2013 - GlaxoSmithKline is in talks with a number of companies interested in buying its Romanian manufacturing facility that was recently earmarked for closure.

Chiron and Panacea End Injectables JV Amicably, Says Novartis

02-Sep-2013 - Novartis-owned Chiron and Panacea Biotec have amicably dissolved their vaccine joint venture due to strategic regions, according to Novartis.

update

CordenPharma Owner Buys Belgian Peptide Firm to Boost API business

29-Aug-2013 - ICIG will buy the Belgian operation of peptide maker Peptisyntha SA from Solvay to expand its recently rejigged contract API business.

Who's Bought Who in the Late Summer Sales

28-Aug-2013 - Amgen spent $10.4bn (€7.8bn) this week on Onyx Pharmaceuticals, but AstraZeneca and Johnson & Johnson have also opened up their wallets this week – welcome to in-Pharmatechnologist.com’s merger & acquisition...

News in brief

Amgen Acquires Onyx for $10.4bn

26-Aug-2013 - Amgen has spent $10.4bn (€7.8bn) in acquiring Onyx Pharmaceuticals saying its oncology products and pipeline will be strengthened by Amgen’s manufacturing capabilities.

Fresenius to Establish Indonesian Manufacturing Hub in 51% Acq

20-Aug-2013 - Fresenius Kabi will focus on intravenous generics and infusion solutions as it acquires a 51 percent stake in an Indonesian pharma company.

Spin Off OTC Unit in Pharmstandard's Vision as it Buys API Supplier

14-Aug-2013 - Pharmstandard says the acquisition of Bever Pharmaceuticals will lower the cost of its API supply as it plans to spin out an OTC business.

Aurobindo Focuses on Injectables with Plans for Spin-Off Subsidiary

13-Aug-2013 - Consolidating its Indian injectable business under a new subsidiary will improve focus and align quality control, says Aurobindo who has invested in two manufacturing companies to support such plans.

Excipients Boost Efficacy in Oral Delivery Platform, says Enteris

06-Aug-2013 - Enteris has acquired an oral drug delivery platform from Unigene Laboratories and says the excipients used can increase solubility and absorption for both peptides and small molecules.

Key Industry Events

 

Access all events listing

Our events, Events from partners...